Company: GEHC
Filing Date: 2025-10-29
Form Type: 10-Q
Source: 0001932393-25-000053
Chunk: 22

Company: GE HealthCare Technologies Inc.
Filing Date: 2025-10-29
Form: 10-Q
Item: Item 1
Chunk 22
---
$81 $59 Non-income based tax receivables23 20 Other sundry receivables91 68 Long-term sundry receivables114 88 Allowance for credit losses(7)(5)Total long-term receivables – net$189 $142 Long-term receivables are recognized within All other non-current assets in the Condensed Consolidated Statements of Financial Position.

NOTE 5. FINANCING RECEIVABLES

Current financing receivables and non-current financing receivables are recognized within All other current assets and All other non-current assets, respectively, in the Condensed Consolidated Statements of Financial Position.As ofSeptember 30, 2025December 31, 2024Loans receivable, at amortized cost$18 $23 Investment in finance leases, net of deferred income77 69 Allowance for credit losses(1)(2)Current financing receivables – net$94 $90 Loans receivable, at amortized cost$44 $35 Investment in finance leases, net of deferred income153 152 Allowance for credit losses(3)(4)Non-current financing receivables – net$194 $183 As of September 30, 2025, 2%, 1%, and 1% of financing receivables were over 30 days past due, over 90 days past due, and on nonaccrual, respectively, with the majority of nonaccrual financing receivables secured by collateral. As of December 31, 2024, 4%, 4%, and 3% of financing receivables were over 30 days past due, over 90 days past due, and on nonaccrual, respectively, with the majority of nonaccrual financing receivables secured by collateral.

NOTE 6. LEASES

Operating lease liabilities recognized within All other current liabilities and All other non-current liabilities in the Condensed Consolidated Statements of Financial Position were $419 million and $385 million as of September 30, 2025 and December 31, 2024, respectively. The total lease expense related to our operating lease portfolio was $63 million and $70 million for the three months ended September 30, 2025 and 2024, respectively, and $185 million and $189 million for the nine months ended September 30, 2025 and